Intelligent Bio Solutions Inc.
INBS · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $1 | $1 | $1 | $1 |
| % Growth | 31.7% | 15.8% | 20% | – |
| Cost of Goods Sold | $1 | $1 | $0 | $0 |
| Gross Profit | $1 | $0 | $0 | $0 |
| % Margin | 46.6% | 39.8% | 46.8% | 36.7% |
| R&D Expenses | $0 | $1 | $0 | $1 |
| G&A Expenses | $0 | $1 | $0 | $2 |
| SG&A Expenses | $3 | $3 | $2 | $2 |
| Sales & Mktg Exp. | $0 | $2 | $0 | $0 |
| Other Operating Expenses | $1 | -$1 | $0 | $0 |
| Operating Expenses | $4 | $3 | $3 | $2 |
| Operating Income | -$3 | -$3 | -$3 | -$2 |
| % Margin | -269.8% | -367.7% | -350.3% | -372.8% |
| Other Income/Exp. Net | $0 | $0 | $0 | $0 |
| Pre-Tax Income | -$3 | -$3 | -$3 | -$2 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$3 | -$3 | -$3 | -$2 |
| % Margin | -268.3% | -366.1% | -349% | -370.3% |
| EPS | -3.5 | -4.4 | -4.4 | -5 |
| % Growth | 20.5% | 0% | 12% | – |
| EPS Diluted | -3.5 | -4.4 | -4.4 | -5 |
| Weighted Avg Shares Out | 1 | 1 | 1 | 0 |
| Weighted Avg Shares Out Dil | 1 | 1 | 1 | 0 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$3 | -$3 | -$2 | -$2 |
| % Margin | -240.7% | -330.9% | -306.5% | -318.6% |